We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Armando Giuliano, MD

Executive Vice Chair, Surgical Oncology in the Department of Surgery

Associate Director, Surgical Oncology in the Samuel Oschin Comprehensive Cancer Institute

Co-Director, Saul and Joyce Brandman Breast Center - A Project of Women's Guild

Professor, Surgery

Linda and Jim Lippman Chair in Surgical Oncology

310 N. San Vicente Blvd.
Third Floor
Los Angeles, CA 90048

Phone:

310-423-9970

Fax:

310-423-9577

Parking Instructions:

Free valet parking is available behind the building.

Armando Giuliano, MD

Executive Vice Chair, Surgical Oncology in the Department of Surgery

Associate Director, Surgical Oncology in the Samuel Oschin Comprehensive Cancer Institute

Co-Director, Saul and Joyce Brandman Breast Center - A Project of Women's Guild

Professor, Surgery

Linda and Jim Lippman Chair in Surgical Oncology

  • Surgical Oncology

Abnormal Mammograms

Breast Biopsy

Breast Cancers

Breast Disorders

Mastectomy

Parathyroid Disorders

Sentinel Lymph Node Biopsy (SLN)

Thyroid Cancers

Thyroid Disorders

Armando Giuliano, MD, has been a clinician-researcher for over 30 years. The main focus of his clinical research continues to be management of early breast cancer and quality of life of breast cancer patients. He served for five years as chairman of the Breast Organ Site Committee of the American College of Surgeons Oncology Group and was study chair for the sentinel node Z0010 and Z0011 studies which led to significant changes to the standard of care for patients with early breast cancer. He was previously a principal investigator for the NSABP and contributed to the lumpectomy study and to Alliance studies. He was a pioneer in sentinel node biopsy. This procedure has enabled early-stage breast cancer patients to avoid having more extensive surgery and reduces the incidence of complications such as lymphedema and shoulder problems. Giuliano also participates in translational research, merging what is learned in the clinic with knowledge gained in the laboratory. Under his direction, the scientists in the Breast Research Laboratory are actively studying triple negative breast cancer, BRCA-positive breast cancer, chemoresistance, and early metastases. Giuliano participates in the NCI's National Clinical Trials Network and is an active member of The Alliance for Clinical Trials in Oncology.

View NIH Biographical Sketch as a PDF

  • Medical School: University of Chicago, 1973
  • Internship: University of California, San Francisco School of Medicine, 1974
  • Residency: University of California, San Francisco School of Medicine, 1976
  • Fellowship: UCLA Medical Center, 1978
  • Residency: University of California, San Francisco School of Medicine, 1980

View CV as a PDF

  • Vice President, Society of Surgical Oncology, 2016-present
  • American College of Surgeons Board of Governors, 2014-17
  • Keynote Address: Lymphadenectomy for Breast Cancer: Past, Present, and Future. American Society of Breast Surgeons 15th Annual Meeting, 2014
  • James Ewing Lecture: The Rise and Fall of Lymphadenectomy for Breast Cancer. Society of Surgical Oncology 66th Annual Cancer Symposium, 2013
  • Distinguished Service Award, University of Chicago, Division of Biological Sciences, 2013
  • President, International Sentinel Node Society, 2012-13
  • Castle Connolly National Physician of the Year Award for Clinical Excellence, 2011
  • Glenn-Robbins Award, New York Metropolitan Breast Cancer Group, 2011
  • Susan G. Komen for the Cure Brinker Award for Scientific Distinction in Clinical Research, 2011
  • Umberto Veronesi Award for International Recognition of Contributions to the Field of Breast Cancer, 2008

Show moreShow less

Click here for a list of peer-reviewed publications.

  • Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis – a randomized clinical trial. JAMA. 2011;305(6):569-575.
  • Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, Morrow M, Leitch AM, Hunt KK, McCall LM, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA. 2011;306(4):385-393.
  • Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver Dl, Benson AB 3rd, Bosserman LD, Burstein JH, Cody H 3rd, Hayman J, Perkins CL, Podoloff DA, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365-1383.
  • Gangi A, Chung A, Mirocha J, Liou DZ, Leong T, Giuliano AE. Breast-conserving therapy for triple-negative breast cancer. JAMA Surg. 2014;149(3):252-258.
  • Giuliano AE, Morrow M, Duggal S, Julian TB. Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer? Clin Exp Metastasis. 2012;29(7):687-692.

Show moreShow less

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Armando Giuliano, MD